Agios licenses blood disorder drug from Oscotec for $25 million upfront
Go back to Agios licenses blood disorder drug from Oscotec for $25 million upfront| AGIOS PHARM (NASDAQ: AGIO) | Delayed: 35.41 +0.31 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.10 | 52 Week High | $71.49 | |||
| Open | $34.82 | 52 Week Low | $33.50 | |||
| Day High | $35.74 | P/E | N/A | |||
| Day Low | $34.63 | EPS | $-1.18 | |||
| Volume | 282,111 | |||||
